We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
295 hedge funds and large institutions have $2.99B invested in Acadia Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 109 increasing their positions, 74 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
141% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 29
137% more call options, than puts
Call options by funds: $18.4M | Put options by funds: $7.74M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
47% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 74
24% more capital invested
Capital invested by funds: $2.4B → $2.99B (+$584M)
15% more funds holding
Funds holding: 256 → 295 (+39)
3.66% more ownership
Funds ownership: 94.25% → 97.91% (+3.7%)
Holders
295
Holders Change
+39
Holders Change %
+15.23%
% of All Funds
3.89%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
70
Increased
109
Reduced
74
Closed
29
Calls
$18.4M
Puts
$7.74M
Net Calls
+$10.6M
Net Calls Change
+$1.01M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$90.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$36M |
| 3 |
SG Americas Securities
New York
|
+$31.7M |
| 4 |
Citigroup
New York
|
+$25M |
| 5 |
Goldman Sachs
New York
|
+$18.1M |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
-$80.7M |
| 2 |
State Street
Boston,
Massachusetts
|
-$23.4M |
| 3 |
Millennium Management
New York
|
-$15.1M |
| 4 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$13.9M |
| 5 |
O
OrbiMed
New York
|
-$11.8M |
